 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- lidocaine gel (CNTX-2022) / Centrexion Therap
New P1 trial: Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain (clinicaltrials.gov) - Feb 10, 2016
P1, N=1, Terminated, Sponsor: Centrexion Therapeutics